Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 11/20 | 0.33 |
| ▸ | CTSL | P07711 | 11/20 | 0.33 |
| ▸ | CTSB | P07858 | 10/20 | 0.33 |
| ▸ | CTSK | P43235 | 7/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7416910 | 1.00 | CTSS (0.33) | CTSSCTSLCTSBCTSK | |
| SCHEMBL7021490 | 0.74 | CTSK (0.56) | CTSSCTSLCTSBCTSK | |
| SCHEMBL7419101 | 0.70 | CTSS (0.53) | CTSSCTSLCTSBCTSK | |
| SCHEMBL7018983 | 0.69 | CTSK (0.58) | CTSSCTSLCTSBCTSK | |
| SCHEMBL7416916 | 0.69 | CTSS (0.35) | CTSSCTSLCTSBCTSK | |
| SCHEMBL7018986 | 0.68 | CTSS (0.43) | CTSSCTSLCTSBCTSK | |
| SCHEMBL6565858 | 0.67 | NR1H4 (0.36) | CTSSCTSLCTSBCTSK | |
| SCHEMBL6565853 | 0.66 | CTSL (0.42) | CTSSCTSLCTSBCTSK | |
| SCHEMBL7021565 | 0.66 | CTSK (0.51) | CTSSCTSLCTSBCTSK | |
| SCHEMBL7021618 | 0.65 | SNCA (0.34) | CTSSCTSLCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1218372-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | Boehringer Ingelheim Pharmaceuticals, Inc. (US) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001019816-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2001-03-22 | — | — | WO | disclosed |